Researchers Reveal More Precise Method of Performing Electroconvulsive Therapy
May 6, 2013 11:06 am | by Elsevier | News | CommentsElectroconvulsive therapy is the most effective acute treatment for severe major depression. However, even with newer forms of ECT, there remains a significant risk of adverse cognitive effects, particularly memory problems. Current theories hold that the regions that need to be stimulated to treat the depression are different and separate from the regions that result in memory problems.
Injectable Nano-Network Controls Blood Sugar in Diabetics for Days at a Time
May 6, 2013 11:02 am | by North Carolina State University | News | CommentsIn a promising development for diabetes treatment, researchers have developed a network of nanoscale particles that can be injected into the body and release insulin when blood-sugar levels rise, maintaining normal blood sugar levels for more than a week in animal-based laboratory tests.
Epilepsy Cured in Mice Using Brain Cells
May 6, 2013 10:26 am | by University of California - San Francisco | News | CommentsUCSF scientists controlled seizures in epileptic mice with a one-time transplantation of medial ganglionic eminence (MGE) cells, which inhibit signaling in overactive nerve circuits, into the hippocampus, a brain region associated with seizures, as well as with learning and memory.
Fully Automated Diagnostic Device Receives CE Certification; IDx LLC Planning For Rollout Across Europe
May 6, 2013 10:26 am | by PR Newswire | News | CommentsIOWA CITY, Iowa, May 6, 2013 /PRNewswire/ -- IDx LLC, a company focused on deploying cutting-edge technology to make medical diagnostics more effective, announced earlier today that its first commercial product, IDx-DR, has received CE approval as a Class IIa medical device.
App Lets Amputees Program Their Own Bionic Hands
May 6, 2013 10:23 am | by The Associated Press | News | CommentsDouble-amputee Jason Koger used to fly to visit a clinician when he wanted to adjust the grips on his bionic hands. Now, he's got an app instead. Koger this week demonstrated the i-limb ultra revolution, a prosthetic developed by the British firm Touch Bionics. Using a stylus and an iPhone, Koger can choose any of 24 grip patterns that best suit his needs.
OrthoAccel® Technologies Introduces New AcceleDent Aura® to U.S. and Canadian Markets
May 6, 2013 10:20 am | by PR Newswire | News | CommentsHOUSTON, May 6, 2013 /PRNewswire/ -- Continuing to follow a remarkable path of innovation and growth, OrthoAccel® Technologies has announced the availability of their newest product, AcceleDent Aura, to orthodontic practices throughout the United States and Canada....
Portable Device Provides Rapid, Accurate Diagnosis
May 6, 2013 10:19 am | by Massachusetts General Hospital | News | CommentsA handheld diagnostic device that Massachusetts General Hospital (MGH) investigators first developed to diagnose cancer has been adapted to rapidly diagnose tuberculosis (TB) and other important infectious bacteria. The portable devices combines microfluidic technology with nuclear magnetic resonance (NMR) to not only diagnose these important infections but also determine the presence of antibiotic-resistant bacterial strains.
Medtronic Announces FDA Approval of New Portfolio Of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators
May 6, 2013 10:18 am | by Medtronic | News | CommentsMedtronic, Inc. has announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of its newest cardiac devices: the Viva® portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices, and the Evera® portfolio of implantable cardioverter-defibrillators (ICD).
AATS Report: Prospective Randomized On-X Heart Valve Clinical Trial (PROACT) Provides Evidence of Reduced Complications
May 6, 2013 9:00 am | by The Associated Press | News | CommentsMINNEAPOLIS--(BUSINESS WIRE)--May 6, 2013--On-X ® Life Technologies, Inc. (On-X LTI) announced today that interim results for the Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT) are being presented at the American Association for Thoracic Surgery Annual (AATS) meeting by John...
AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core Lab
May 6, 2013 9:00 am | by PR Newswire | News | CommentsBOSTON, May 6, 2013 /PRNewswire/ -- AG Mednet today announced a new core lab partnership with the Methodist DeBakey Heart & Vascular Center (MDHVC) echocardiography core laboratory at The Methodist Hospital in Houston. By selecting AG Mednet quality assurance and compliance...
Polycom Helps Healthcare Organizations Reduce Unnecessary Rehospitalizations, Supports Prevention and Wellness with New Video Collaboration Solutions for Robotics, Mobile Devices and Web Browsers
May 6, 2013 8:30 am | by The Associated Press | News | CommentsAUSTIN, Texas--(BUSINESS WIRE)--May 6, 2013--AMERICAN TELEMEDICINE ASSOCIATION CONFERENCE– Helping healthcare organizations improve medical care, and supporting prevention and wellness initiatives with HD video collaboration, Polycom, Inc. (Nasdaq: PLCM), the global leader in open, standards-based...
Hansen Medical to Exhibit Magellan Robotic System at 8th Annual European Symposium of Vascular Biomaterials in France
May 6, 2013 8:03 am | by The Associated Press | News | CommentsHansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that it will be exhibiting its Magellan Robotic System at the 8th Annual European Symposium of Vascular Biomaterials (ESVB) from Friday, May 10th to Monday, May 13th at the Strasbourg Hilton in...
Tactio Launches a Remote Patient Monitoring Mobile Health Solution to Control, Manage and Coach Type 1, Type 2, and Gestational Diabetes
May 6, 2013 8:00 am | by The Associated Press | News | CommentsAUSTIN, Texas--(BUSINESS WIRE)--May 6, 2013--Tactio Health Group announces the launch of TactioDiabetes, a diabetes-management tool that will help patients easily track several aspects of their lifestyle, including: TactioHealth App with TactioDiabetes Option tracking Type 1 Diabetes with Insulin...
Transgenomic Signs Collaboration Agreement with Amgen for Development of CE-IVD CRC RAScan™ Mutation Detection Tests for Patients with Metastatic Colorectal Cancer
May 6, 2013 7:00 am | by The Associated Press | News | CommentsOMAHA, Neb.--(BUSINESS WIRE)--May 6, 2013--Transgenomic, Inc. (OTCBB: TBIO) today announced that it has entered into a collaboration with Amgen Inc. (NASDAQ: AMGN) to develop a CE-IVD test to screen patients with metastatic colorectal cancer (mCRC) for RAS mutations ( KRAS and NRAS ). These RAS...
Sanitary Temperature Control Systems
May 3, 2013 5:28 pm | by MDT Staff | Mokon | Product Releases | CommentsMokon is producing high quality heating and cooling systems that provide precise temperature control of process fluids in sanitary environments. Typical applications include: electronic circuit boards and components, biotechnology and pharmaceutical, medicine and vitamin packaging, and surgical equipment and devices.


